Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy
- PMID: 30680862
- PMCID: PMC6467058
- DOI: 10.1002/anie.201812759
Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy
Abstract
Hyperpolarized magnetic resonance spectroscopy enables quantitative, non-radioactive, real-time measurement of imaging probe biodistribution and metabolism in vivo. Here, we investigate and report on the development and characterization of hyperpolarized acetylsalicylic acid (aspirin) and its use as a nuclear magnetic resonance (NMR) probe. Aspirin derivatives were synthesized with single- and double-13 C labels and hyperpolarized by dynamic nuclear polarization with 4.7 % and 3 % polarization, respectively. The longitudinal relaxation constants (T1 ) for the labeled acetyl and carboxyl carbonyls were approximately 30 seconds, supporting in vivo imaging and spectroscopy applications. In vitro hydrolysis, transacetylation, and albumin binding of hyperpolarized aspirin were readily monitored in real time by 13 C-NMR spectroscopy. Hyperpolarized, double-labeled aspirin was well tolerated in mice and could be observed by both 13 C-MR imaging and 13 C-NMR spectroscopy in vivo.
Keywords: aspirin; chemopreventive; hyperpolarization; magnetic resonance imaging; magnetic resonance spectroscopy.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Conflict of interest statement
Conflict of interest
The authors declare no conflict of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- P50 CA221707/CA/NCI NIH HHS/United States
- 5R01CA1722670/CA/NCI NIH HHS/United States
- R21 CA181994/CA/NCI NIH HHS/United States
- PC110065/Congressionally Directed Medical Research Programs/International
- RP180164/Cancer Prevention and Research Institute of Texas/International
- R44 CA206771/CA/NCI NIH HHS/United States
- KL2 TR000370/TR/NCATS NIH HHS/United States
- R21 CA185536/CA/NCI NIH HHS/United States
- RP170593/Cancer Prevention and Research Institute of Texas/International
- P30 CA016672/CA/NCI NIH HHS/United States
- R25 CA057730/CA/NCI NIH HHS/United States
- R01 CA184843/CA/NCI NIH HHS/United States
- R01 CA187238/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
